DexCom, Inc. (DXCM)
67.40
-1.03
(-1.51%)
USD |
NASDAQ |
Jan 09, 16:00
67.34
-0.06
(-0.09%)
After-Hours: 20:00
DexCom Research and Development Expense (Quarterly): 157.50M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| BioLife Solutions, Inc. | 2.709M |
| Abbott Laboratories | 748.00M |
| Krystal Biotech, Inc. | 13.18M |
| Boston Scientific Corp. | 514.00M |
| Tandem Diabetes Care, Inc. | 47.88M |